Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancer
Katherine Foster(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Shannon N. Westin(The University of Texas MD Anderson Cancer Center), Deanna Glassman(The University of Texas MD Anderson Cancer Center), Jose Alejandro Rauh‐Hain(The University of Texas MD Anderson Cancer Center), Yuexin Liu(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Timothy A. Yap(The University of Texas MD Anderson Cancer Center), Bryan Fellman(The University of Texas MD Anderson Cancer Center), Nicole D. Fleming(The University of Texas MD Anderson Cancer Center), Sanghoon Lee(The University of Texas MD Anderson Cancer Center), Zhenlin Ju(The University of Texas MD Anderson Cancer Center), Kenna Shaw(Center for Personalized Cancer Treatment), Fengyi Jin(The University of Texas MD Anderson Cancer Center)
Cited by 9
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k